| Financial Year |
March 31 2023 |
| Monetary Funds |
825,442,549.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
46,946,305.69 |
| Advances to Suppliers |
217,316,278.06 |
| Other Receivables |
103,793,268.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,731,780,888.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
51,968,525.70 |
| Total Current Assets |
2,977,247,816.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
336,052,191.27 |
| Investment Properties |
41,364,892.10 |
| Fixed Assetes |
1,288,905,599.02 |
| Under-construction Projects |
589,676,033.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
822,789,106.04 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
164,255,171.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
34,665,780.93 |
| Deferred Income Tax Assets |
9,342,709.35 |
| Other Non-Current Assets |
54,033,373.86 |
| Sub-Total of Non-Current Assets |
7,853,915,391.73 |
| Total Assets |
10,831,163,207.93 |
| Short-Term Loans |
906,906,801.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
556,897,319.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
78,637,809.48 |
| Taxes Payable |
8,377,103.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
455,178,002.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
287,253,815.12 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,342,955,627.82 |
| Long-term Loans |
1,707,545,349.35 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
459,533.58 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
590,000.00 |
| Sub-Total of Non-Current Liabilities |
5,820,795,783.87 |
| Total Liabilities |
8,163,751,411.69 |
| Paid-In Capital(Or Share Stock) |
1,076,479,236.00 |
| Capital Surplus |
1,299,929,645.56 |
| Surplus Reserve |
111,671,556.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-31,720,438.91 |
| Minority Stockholder's Interest |
211,051,796.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,456,359,999.37 |
| Owner's Equity（Stockholder's Equity） |
2,667,411,796.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,831,163,207.93 |
